ACTG Network Monthly Newsletter - August 2016

Published Date:

08/30/2016

Publication:

ACTG

Women's Outreach Workers Project Releases New Educational Video


New Video Addresses Questions Women and Minorities May Have Regarding ACTG Network Clinical Trials

The Women's Outreach Workers (WOW) Project was established with the goal of developing optimal strategies for increasing recruitment and retention of women, particularly women of color in ACTG Network clinical trials. Led by Susan E. Cohn, MD, MPH, Investigator at our Northwestern University Site, and working in collaboration with the Women's Health Inter-Network Scientific Committee (WHISC) and the Underrepresented Populations Committee (UPC), the WOW Project team created an educational video to help to answer many questions women and minorities may have about participating in ACTG Network clinical trials.


Click HERE for the rest of the article and to view the video.

Clinical Trials

A5274: REMEMBER, Reducing Early Mortality and Early...

This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...

Read More

A5282: A Randomized, Phase II Trial to Compare an HPV...

The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...

Read More

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More

A5320: Viral Hepatitis C Infection Long-term Cohort Study...

A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...

Read More

A5332: Randomized Trial to Prevent Vascular Events in HIV...

REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....

Read More